3rd Quarter - Report

NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)

Firm
Client
Income
—
Expenses
$60,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Rare Disease Initiatives. Newborn Screening. Affordable Care Act (ACA) Issues and Enhancements. Step Therapy. Telehealth. Priority Review Voucher Reauthorization. H.R.6892: Medical Nutrition Equity Act of 2023.

LobbyistCovered position, as disclosed
MASON OLIVER BARRETT —
HAYLEY DEMPSEY —
KARIN HOELZER —
HEIDI ROSS —
SUPRAJA SOWMIYANARAYAN —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 6892 (118th)

Medicare/Medicaid MMM

Medicare / Medicaid issues impacting patients with rare diseases. Inflation Reduction Act Implementation.

LobbyistCovered position, as disclosed
MASON OLIVER BARRETT —
HAYLEY DEMPSEY —
KARIN HOELZER —
HEIDI ROSS —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. H.R.7383/S.1214: RARE Act. Inflation Reduction Act Implementation. PRV Reauthorization. Lab-developed tests.

LobbyistCovered position, as disclosed
MASON OLIVER BARRETT —
HAYLEY DEMPSEY —
KARIN HOELZER —
HEIDI ROSS —
SUPRAJA SOWMIYANARAYAN —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1214 (118th), H.R. 7383 (118th)

Budget/Appropriations BUD

Appropriations impacting patients with rare diseases. National Institutes of Health (NIH) NCATS Appropriations.

LobbyistCovered position, as disclosed
MASON OLIVER BARRETT —
KARIN HOELZER —

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.